Ovid Therapeutics Presents Additional Data and Analyses from the Phase 2 STARS Clinical Trial with OV101
Bold Ventures Commences Summer Fieldwork at Burchell, Follows up at 111 Zone and JET Rare Earth Element System
Goldgroup Closes Purchase of the San Francisco Gold Mine Acquiring 100% of Molimentales Del Noroeste, S.A. de C.V.
